Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug th-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma
If regulators sign off, Horn and other experts say orforglipron could reach clinics as soon as 2026, though realworld factors such as price, insurance coverage, and how well patients tolerate the drug will ultimately decide how widely it is used
Always aim for the vial wall
LixiLan combines lixisenatide with Sanofis Lantus (insulin glargine) in a single product, although this will likely have competition from a rival combo from Novo Nordisk, combining long-acting insulin Tresiba (insulin degludec) with Victoza
Raw powder is stable at room temperature but lasts longer refrigerated
Simply enter your height in feet and inches and then weight in pounds to see your BMI